Researchers in China have discovered that the vitamin B5 derivative pantethine limits the activity of immune cells that are key contributors to autoimmune diseases such as psoriasis. The study, published in the Journal of Experimental Medicine, shows that pantethine prevents the development of psoriasis in mice and also helps alleviate the symptoms of psoriasis patients in a small-scale human trial.
Vitamin B5 Derivative Pantethine Shows Promise in Psoriasis Treatment
Researchers in China have found that pantethine, a vitamin B5 derivative, can limit immune cell activity related to autoimmune diseases like psoriasis. This discovery shows promise in treating psoriasis in both mice and a small human trial. The findings could be significant for Iran as they may influence local healthcare approaches to autoimmune diseases.
👥 Key Players
📰 What Happened
Researchers in China have found that pantethine, a vitamin B5 derivative, can limit immune cell activity related to autoimmune diseases like psoriasis. This discovery shows promise in treating psoriasis in both mice and a small human trial.
- Pantethine prevents the development of psoriasis in mice.
- A small-scale human trial showed improvement in psoriasis symptoms.
💡 Why It Matters
📚 Background
Psoriasis is a chronic autoimmune condition that affects millions worldwide, and current treatments can be limited or ineffective for some patients. Research into new therapies is crucial for improving patient care.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%